Trials / Recruiting
RecruitingNCT05270902
Haemoadsorption During Heart Transplantation
Effect of Haemoadsorption During Cardiopulmonary Bypass on Patients After Heart Transplantation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether the use of haemoadsorption (HA) on cardiopulmonary bypass during heart transplantation (HTX) has an effect on circulating cytokine levels for the first 120 hours after HTX and induces a decreased inflammatory response, increased anti-inflammatory response or immunosuppressive response. Additionally, the influence of HA on primary graft dysfunction, postoperative cerebral dysfunction, postoperative fluid accumulation, renal dysfunction, duration of mechanical ventilation, length of ICU-stay and 30-day mortality should be investigated
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytoSorb Adsorber | Polymer based adsorber system for the elimination of cytokines |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2025-12-31
- Completion
- 2026-06-30
- First posted
- 2022-03-08
- Last updated
- 2025-05-09
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT05270902. Inclusion in this directory is not an endorsement.